Drs. Basta and Petkovich receive CIHR funding
Published Mon Jul 22nd 2013
Ten Queen’s University researchers were awarded over $5.35 million from the Canadian Institutes of Health Research (CIHR) during the 2012/13 fiscal term. The funding is being used to support the creation of new scientific knowledge that could lead to better understanding of illnesses and disorders and, ultimately, better health of Canadians. “The support of the CIHR is vital to our researchers,” says Steven Liss, Vice-Principal (Research). “Queen’s is a leader in health research and this funding will help our researchers remain on the leading edge of those breakthroughs.”
The following DBMS researchers have received funding:
Sameh Basta (Biomedical and Molecular Sciences) – Dr. Basta is investigating how viral infections influence our immune response to other stimuli. This will help in the development of new therapeutic approaches to alleviate ill health.
Martin Petkovich (Biomedical and Molecular Sciences; Cancer Research Institute) – Dr. Petkovich is examining whether inhibiting or removing retinoic acid can prevent or reverse the formation of bone in soft tissues, called ectopic bone formation, which can lead to cardiovascular disease and death. Currently there are few treatments for this type of bone formation.
Visit the CIHR website for more information about the most recent grant announcements.
Full story at https://www.queensu.ca/news/articles/queens-health-researchers-awarded-535-million